Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
Enovis total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Enovis's total debt was $1.28B at Jul 3, 2026. For fiscal 2025 it was $1.30B, down 2.5% from the year before. Over ten years it grew -0.9% a year on average. The highest annual figure on record is $2.31B in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30B | -2.5% |
| FY2024 | Dec 31, 2024 | $1.33B | +185.2% |
| FY2023 | Dec 31, 2023 | $466.16M | +79.8% |
| FY2022 | Dec 31, 2022 | $259.28M | -87.6% |
| FY2021 | Dec 31, 2021 | $2.09B | -6.5% |
| FY2020 | Dec 31, 2020 | $2.23B | -3.5% |
| FY2019 | Dec 31, 2019 | $2.31B | +93.1% |
| FY2018 | Dec 31, 2018 | $1.20B | +12.9% |
| FY2017 | Dec 31, 2017 | $1.06B | -17.9% |
| FY2016 | Dec 31, 2016 | $1.29B | -8.8% |
| FY2015 | Dec 31, 2015 | $1.42B | -7.8% |
| FY2014 | Dec 31, 2014 | $1.54B | +3.3% |
| FY2013 | Dec 31, 2013 | $1.49B | -14.0% |
| FY2012 | Dec 31, 2012 | $1.73B | +1449.8% |
| FY2011 | Dec 31, 2011 | $111.52M | +35.2% |
| FY2010 | Dec 31, 2010 | $82.50M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $1.28B | -7.8% |
| Q1 FY2026 | Apr 3, 2026 | $1.33B | -4.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.30B | -2.5% |
| Q3 FY2025 | Oct 3, 2025 | $1.36B | +1.0% |
| Q2 FY2025 | Jul 4, 2025 | $1.39B | +3.7% |
| Q1 FY2025 | Apr 4, 2025 | $1.39B | +3.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.33B | +185.2% |
| Q3 FY2024 | Sep 27, 2024 | $1.35B | +240.6% |
| Q2 FY2024 | Jun 28, 2024 | $1.34B | +236.1% |
| Q1 FY2024 | Mar 29, 2024 | $1.34B | +369.7% |
| Q4 FY2023 | Dec 31, 2023 | $466.16M | +79.8% |
| Q3 FY2023 | Sep 29, 2023 | $395.00M | -12.1% |
| Q2 FY2023 | Jun 30, 2023 | $400.00M | -11.0% |
| Q1 FY2023 | Mar 31, 2023 | $285.00M | -86.2% |
| Q4 FY2022 | Dec 31, 2022 | $259.28M | -87.6% |
| Q3 FY2022 | Sep 30, 2022 | $449.22M | -72.4% |
| Q2 FY2022 | Jul 1, 2022 | $449.46M | -71.9% |
| Q1 FY2022 | Apr 1, 2022 | $2.07B | -6.3% |
| Q4 FY2021 | Dec 31, 2021 | $2.09B | -6.5% |
| Q3 FY2021 | Oct 1, 2021 | $1.63B | -26.7% |
| Q2 FY2021 | Jul 2, 2021 | $1.60B | -28.9% |
| Q1 FY2021 | Apr 2, 2021 | $2.21B | -13.0% |
| Q4 FY2020 | Dec 31, 2020 | $2.23B | -3.5% |
| Q3 FY2020 | Oct 2, 2020 | $2.22B | -45.0% |
| Q2 FY2020 | Jul 3, 2020 | $2.25B | -45.4% |
| Q1 FY2020 | Apr 3, 2020 | $2.54B | -39.1% |
| Q4 FY2019 | Dec 31, 2019 | $2.31B | +93.1% |
| Q3 FY2019 | Sep 27, 2019 | $4.03B | +253.1% |
| Q2 FY2019 | Jun 28, 2019 | $4.12B | +283.5% |
| Q1 FY2019 | Mar 29, 2019 | $4.17B | +269.9% |
| Q4 FY2018 | Dec 31, 2018 | $1.20B | +12.9% |
| Q3 FY2018 | Sep 28, 2018 | $1.14B | -14.8% |
| Q2 FY2018 | Jun 29, 2018 | $1.07B | -19.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.13B | +6.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.06B | -17.9% |
| Q3 FY2017 | Sep 29, 2017 | $1.34B | -3.2% |
| Q2 FY2017 | Jun 30, 2017 | $1.33B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.06B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.29B | – |
| Q3 FY2016 | Sep 30, 2016 | $1.39B | – |
See a number that looks wrong?